Quantum Biopharma (QNTM) Non Operating Income (2022 - 2024)
Quantum Biopharma's (QNTM) quarterly Non Operating Income came in at -$10371.0 in Q3 2024, down 2829.21% year-over-year from $380.0 in Q4 2023, and down 2829.21% quarter-over-quarter from $380.0 in Q3 2023.
Powered by 
Analysis
Quantum Biopharma (QNTM) Non Operating Income (2022 - 2024) Analysis & Trends
Quantum Biopharma has disclosed Non Operating Income across 3 years of filings, most recently posting -$10371.0 for Q3 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | -73.00 Mn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | 387.00 Mn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 234.30 Mn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | - |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | -53.64 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | - |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | - |
| 10 | Quantum Biopharma | 12.60 Mn | 7.09 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | -10,371.00 |
| Sep 30, 2023 | 380.00 |
| Sep 30, 2022 | 16,052.00 |